Split History
SCLN split history picture
SCLN (SCLN) has 1 split in our SCLN split history database. The split for SCLN took place on August 09, 1993. This was a 1 for 3 reverse split, meaning for each 3 shares of SCLN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 333.333333333333 share position following the split.

When a company such as SCLN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SCLN split history from start to finish, an original position size of 1000 shares would have turned into 333.333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SCLN shares, starting with a $10,000 purchase of SCLN, presented on a split-history-adjusted basis factoring in the complete SCLN split history. SCLN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/30/2012
End date: 10/13/2017
Start price/share: $6.31
End price/share: $11.15
Dividends collected/share: $0.00
Total return: 76.70%
Average Annual Total Return: 11.17%
Starting investment: $10,000.00
Ending investment: $17,668.48
Years: 5.38
SciClone Pharmaceuticals is a pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. Co.'s business is focused primarily on the People's Republic of China. Co. operates in two segments which are based on the nature and location of its customers: China and the Rest of the World, which includes its U.S. and Hong Kong operations. Co.'s primary product, ZADAXIN (thymalfasin), is approved in over 30 countries and may be used for the treatment of the hepatitis B virus, hepatitis C virus, and certain cancers, and as an immune system enhancer according to the local regulatory approvals Co. has in these countries. According to our SCLN split history records, SCLN has had 1 split.
Date Ratio
08/09/19931 for 3
SCLN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SCYX Split History
SELB Split History
SEM Split History
SGNL Split History
SGYP Split History
SKBI Split History
SKLN Split History
SLNO Split History
SLS Split History
SLXP Split History

Email EnvelopeFree SCLN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Blue Hat Interactive Entertainment Technology (BHAT)
Baosheng Media Group Holdings Limited (BAOS)
Salisbury Bancorp, Inc. (SAL)
Global X Cannabis ETF (POTX)
Kinetik Holdings Inc. (KNTK)
China SXT Pharmaceuticals, Inc. (SXTC)
PolarityTE, Inc. (PTE)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Surgalign Holdings, Inc. (SRGA)
Rockwell Medical, Inc. (RMTI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SCLN Insider Buying

SCLN Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.